StimCardio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $30M

  • Investors
  • 12

StimCardio General Information

Description

Developer of a wearable device designed for non-invasive treatment and monitoring of atrial fibrillation at home. The company's device is based on a closed-loop approach and machine learning algorithms that utilize non-invasive, personalized peripheral neuromodulation to mediate a cardiovascular antiarrhythmic response, enabling patients to reduce the burden of atrial fibrillation and its precursors, resulting in rapid clinical and symptomatic relief.

Contact Information

Formerly Known As
CardiaCare
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1925 Century Park East
  • Suite 1700
  • Los Angeles, CA 90067
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Other Healthcare Technology Systems
Corporate Office
  • 1925 Century Park East
  • Suite 1700
  • Los Angeles, CA 90067
  • United States

StimCardio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StimCardio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 29-Oct-2026 $30M Completed Generating Revenue
5. Accelerator/Incubator 07-Oct-2025 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
3. Seed Round 01-Aug-2023 Completed Generating Revenue
2. Accelerator/Incubator 01-Jun-2022 Completed Generating Revenue
1. Seed Round 01-Aug-2018 Completed Generating Revenue
To view StimCardio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

StimCardio Patents

StimCardio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026229977-A1 Methods and systems for managing stress such as in anxiety Pending 29-Apr-2025
WO-2025243290-A1 Post ablation autonomic nervous system neuromodulation treatment Pending 20-May-2024
EP-4277699-A1 Monitoring and treating atrial fibrillation, arrythmia, and additional conditions Pending 18-Jan-2021
EP-4277699-A4 Monitoring and treating atrial fibrillation, arrythmia, and additional conditions Pending 18-Jan-2021
US-20240091533-A1 Monitoring and treating atrial fibrillation, arrythmia, and additional conditions Pending 18-Jan-2021 A61N1/36031
To view StimCardio’s complete patent history, request access »

StimCardio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StimCardio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Catalyst Health Ventures Venture Capital Minority
MedTech Angels Angel Group Minority
Metis Medtech Venture Capital Minority
New Mexico Angels Angel Group Minority
New York Angels Angel Group Minority
You’re viewing 5 of 12 investors. Get the full list »

StimCardio FAQs

  • When was StimCardio founded?

    StimCardio was founded in 2018.

  • Where is StimCardio headquartered?

    StimCardio is headquartered in Los Angeles, CA.

  • What is the size of StimCardio?

    StimCardio has 6 total employees.

  • What industry is StimCardio in?

    StimCardio’s primary industry is Therapeutic Devices.

  • Is StimCardio a private or public company?

    StimCardio is a Private company.

  • What is StimCardio’s current revenue?

    The current revenue for StimCardio is .

  • How much funding has StimCardio raised over time?

    StimCardio has raised $30M.

  • Who are StimCardio’s investors?

    Catalyst Health Ventures, MedTech Angels, Metis Medtech, New Mexico Angels, and New York Angels are 5 of 12 investors who have invested in StimCardio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process